FilingSEC EDGAR8-K
Jasper Therapeutics Announces CFO Resignation and Interim Appointments
· SEC accepted
StageManagement Change
Filing content
CFO Herb Cross will resign effective October 9, with CEO Jeet Mahal and VP Rick Ruiz assuming interim financial and accounting roles, respectively.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…